Cullen/Frost Bankers’s Altimmune ALT Stock Holding History

Cullen/Frost Bankers’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$50K	–	1302
2025 Q1	$50K	Hold	10,000	–	–	﹤0.01%	722
2024 Q4	$72.1K	Buy	+10,000	New	+$76.4K	﹤0.01%	649
2021 Q2	–	Sell	-10,000	Closed	-$141K	–	1198
2021 Q1	$141K	Hold	10,000	–	–	﹤0.01%	569
2020 Q4	$113K	Hold	10,000	–	–	﹤0.01%	561
2020 Q3	$132K	Hold	10,000	–	–	﹤0.01%	521
2020 Q2	$107K	Buy	+10,000	New	+$54.9K	﹤0.01%	527

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cullen/Frost Bankers's ALT Position: Q2 2025 in Review

Cullen/Frost Bankers sold out of Altimmune (ALT) in Q2 2025, closing a stake of 10,000 shares — an estimated $50K sold.

Cullen/Frost Bankers first reported a position in ALT in Q2 2020 and held it in 6 quarters. The position peaked at $141K in Q1 2021. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

Cullen/Frost Bankers reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
Cullen/Frost Bankers sold 10,000 Altimmune shares in Q2 2025, an estimated $50K.
Cullen/Frost Bankers first reported a position in Altimmune in Q2 2020 and held it in 6 quarters.
Cullen/Frost Bankers's Altimmune position peaked at $141K in Q1 2021.
180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Cullen/Frost Bankers's 13F filing for Q2 2025, filed 30 Jul 2025.